Evolving Landscape of Paediatric Inflammatory Bowel Disease: Insights from a Decade-Long Study in North-East Slovenia on Incidence, Management, Diagnostic Delays, and Early Biologic Intervention

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2024 Jan 22

PMID 38248065

Authors

Martina Klemenak

Manca Zupan

Petra Riznik

Tomaz Krencnik

Jernej Dolinsek

Affiliations

Soon will be listed here.

Abstract

Background: In the past decade, significant progress has been achieved in the care of children with inflammatory bowel disease (IBD). Our study concentrated on assessing the incidence and management of IBD in children in North-Eastern Slovenia over a 10-year period.

Methods: Medical data from children and adolescents diagnosed with IBD in North-Eastern Slovenia (2014-2023) was analysed. Disease incidence and management of children were assessed. Findings were compared between two periods (2014-2019 and 2020-2023, coinciding with the COVID-19 pandemic).

Results: 87 patients (median age 15.5 year; 50.6% male) with IBD (43.7% Crohn's disease (CD)), diagnosed between 2014 and 2023 were included. Extraintestinal manifestations were more common in CD than ulcerative colitis (UC) (15.8% vs. 2.4%, < 0.05). Median delay from symptom onset to diagnosis was 2 months, lower in UC than CD (NS). Mean annual IBD incidence per 100,000 children aged 0 to 19 years was 6.4 (95% CI 4.4-8.3), slightly lower for CD than UC (2.8/100,000 vs. 3.1/100,000). In the second period, IBD incidence significantly rose (9.1 vs. 4.6, < 0.05). During this period, 53% of CD patients transitioned to biological treatment within three months of diagnosis.

Conclusion: IBD incidence rose among children in North-Eastern Slovenia over the past decade. Additionally, more children with CD underwent biological therapy in the second period.

References

Kuenzig M, Fung S, Marderfeld L, Mak J, Kaplan G, Ng S . Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review. Gastroenterology. 2022; 162(4):1147-1159.e4. DOI: 10.1053/j.gastro.2021.12.282. View

van Rheenen P, Aloi M, Assa A, Bronsky J, Escher J, Fagerberg U . The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update. J Crohns Colitis. 2020; . DOI: 10.1093/ecco-jcc/jjaa161. View

Manuel A, Magalhaes T, Granado M, Espinheira M, Trindade E . EVOLUTION OF DIAGNOSTIC DELAY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE AND THE IMPACT OF THE COVID-19 PANDEMIC. Arq Gastroenterol. 2023; 60(1):91-97. DOI: 10.1590/S0004-2803.202301000-12. View

Kaplan J, Liu C, King E, Bass J, Patel A, Tung J . Use, Durability, and Risks for Discontinuation of Initial and Subsequent Biologics in a Large Pediatric-Onset IBD Cohort. J Pediatr Gastroenterol Nutr. 2023; 76(5):566-575. PMC: 10097486. DOI: 10.1097/MPG.0000000000003734. View

Khalilipour B, Day A, Kenrick K, Schultz M, Aluzaite K . Diagnostic Delay in Paediatric Inflammatory Bowel Disease-A Systematic Investigation. J Clin Med. 2022; 11(14). PMC: 9316086. DOI: 10.3390/jcm11144161. View

Adam H, Alqassas M, Saadah O, Mosli M . Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients. J Epidemiol Glob Health. 2020; 10(4):298-303. PMC: 7758850. DOI: 10.2991/jegh.k.200330.001. View

Choe J, Choi S, Song K, Jang H, Choi K, Yi D . Incidence and Prevalence Trends of Pediatric Inflammatory Bowel Disease in the Daegu-Kyungpook Province From 2017 to 2020. Front Pediatr. 2022; 9:810173. PMC: 8764442. DOI: 10.3389/fped.2021.810173. View

Bouhuys M, Lexmond W, van Rheenen P . Pediatric Inflammatory Bowel Disease. Pediatrics. 2022; 151(1). DOI: 10.1542/peds.2022-058037. View

De Greef E, John J, Hoffman I, Smets F, Van Biervliet S, Scaillon M . Profile of pediatric Crohn's disease in Belgium. J Crohns Colitis. 2013; 7(11):e588-98. DOI: 10.1016/j.crohns.2013.04.016. View

10.

Cantoro L, Monterubbianesi R, Falasco G, Camastra C, Pantanella P, Allocca M . The Earlier You Find, the Better You Treat: Red Flags for Early Diagnosis of Inflammatory Bowel Disease. Diagnostics (Basel). 2023; 13(20). PMC: 10605540. DOI: 10.3390/diagnostics13203183. View

11.

Yu Y, Rodriguez J . Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Semin Pediatr Surg. 2017; 26(6):349-355. DOI: 10.1053/j.sempedsurg.2017.10.003. View

12.

Ashton J, Barakat F, Barnes C, Coelho T, Batra A, Afzal N . Incidence and Prevalence of Paediatric Inflammatory Bowel Disease Continues to Increase in the South of England. J Pediatr Gastroenterol Nutr. 2022; 75(2):e20-e24. DOI: 10.1097/MPG.0000000000003511. View

13.

Niseteo T, Sila S, Trivic I, Misak Z, Kolacek S, Hojsak I . Modified Crohn's disease exclusion diet is equally effective as exclusive enteral nutrition: Real-world data. Nutr Clin Pract. 2021; 37(2):435-441. DOI: 10.1002/ncp.10752. View

14.

Kern I, Schoffer O, Richter T, Kiess W, Flemming G, Winkler U . Current and projected incidence trends of pediatric-onset inflammatory bowel disease in Germany based on the Saxon Pediatric IBD Registry 2000-2014 -a 15-year evaluation of trends. PLoS One. 2022; 17(9):e0274117. PMC: 9462751. DOI: 10.1371/journal.pone.0274117. View

15.

Atia O, Ledder O, Ben-Moshe T, Lev-Tzion R, Rachmen Y, Meyer E . Role of Thiopurines in Pediatric Inflammatory Bowel Diseases: A Real-Life Prospective Cohort Study. J Pediatr Gastroenterol Nutr. 2020; 70(6):825-832. DOI: 10.1097/MPG.0000000000002566. View

16.

El Mouzan M, AlSaleem B, Hasosah M, Al-Hussaini A, Al Anazi A, Saadah O . Diagnostic delay of pediatric inflammatory bowel disease in Saudi Arabia. Saudi J Gastroenterol. 2019; 25(4):257-261. PMC: 6714469. DOI: 10.4103/sjg.SJG_457_18. View

17.

Ruemmele F, Veres G, Kolho K, Griffiths A, Levine A, Escher J . Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. J Crohns Colitis. 2014; 8(10):1179-207. DOI: 10.1016/j.crohns.2014.04.005. View

18.

Orel R, Kamhi T, Vidmar G, Mamula P . Epidemiology of pediatric chronic inflammatory bowel disease in central and western Slovenia, 1994-2005. J Pediatr Gastroenterol Nutr. 2009; 48(5):579-86. DOI: 10.1097/MPG.0b013e318164d903. View

19.

Shan C, Zhang Q, Xiao Y, Wang X, Yu Y, Xu X . [Incidence and risk factors of extraintestinal manifestations in children with inflammatory bowel disease]. Zhonghua Er Ke Za Zhi. 2019; 57(9):694-699. DOI: 10.3760/cma.j.issn.0578-1310.2019.09.009. View

20.

Turner D, Ruemmele F, Orlanski-Meyer E, Griffiths A, de Carpi J, Bronsky J . Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018; 67(2):257-291. DOI: 10.1097/MPG.0000000000002035. View